Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Cancer Non-Small Cell Stage II”

2,339 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,339 results

Testing effectiveness (Phase 2)UnknownNCT03848611
What this trial is testing

CM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).

Who this might be right for
Non-small Cell Lung Cancer
AnewPharma 20
Testing effectiveness (Phase 2)Study completedNCT00684099
What this trial is testing

Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 70
Testing effectiveness (Phase 2)Study completedNCT04245085
What this trial is testing

ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma

Who this might be right for
EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC
ETOP IBCSG Partners Foundation 95
Testing effectiveness (Phase 2)Study completedNCT00004238
What this trial is testing

10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT00818558
What this trial is testing

The Method ISET (Insulation by Size of Epithelial Tumor Cells)

Who this might be right for
Non Small Cell Lung Cancer
Centre Hospitalier Universitaire de Nice 520
Testing effectiveness (Phase 2)UnknownNCT02006043
What this trial is testing

Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Treatment in NSCLC With EGFR M(-) and C-met(-)

Who this might be right for
Non-small Cell Lung Cancer
Li Zhang 54
Testing effectiveness (Phase 2)WithdrawnNCT00951444
What this trial is testing

Gemcitabine Hydrochloride and Carboplatin With or Without MK-0646 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)UnknownNCT00033722
What this trial is testing

Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Tularik
Large-scale testing (Phase 3)Active Not RecruitingNCT02595944
What this trial is testing

Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)

Who this might be right for
Stage IB Lung Non-Small Cell Carcinoma AJCC v7Stage II Lung Non-Small Cell Cancer AJCC v7Stage IIIA Lung Non-Small Cell Cancer AJCC v7
National Cancer Institute (NCI) 903
Testing effectiveness (Phase 2)Study completedNCT02031458
What this trial is testing

Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 667
Testing effectiveness (Phase 2)Study completedNCT00492206
What this trial is testing

Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
University of Pittsburgh 40
Testing effectiveness (Phase 2)Study completedNCT00269152
What this trial is testing

Feasibility Study of Pemetrexed in Combination With Cisplatin or Carboplatin as Adjuvant Treatment of Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Eli Lilly and Company 122
Testing effectiveness (Phase 2)Study completedNCT00391248
What this trial is testing

Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL)

Who this might be right for
Non-small Cell Lung Cancer
Ontario Clinical Oncology Group (OCOG) 40
Early research (Phase 1)Study completedNCT00032032
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 69
Post-approval studies (Phase 4)Study completedNCT01196078
What this trial is testing

Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 114
Testing effectiveness (Phase 2)Study completedNCT02321540
What this trial is testing

A Phase I/II Study of Ibrutinib in Previously Treated Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Looking for participantsNCT07169552
What this trial is testing

HC010 in First-line PD-L1 Positive Advanced NSCLC Patients

Who this might be right for
NSCLC
HC Biopharma Inc. 50
Testing effectiveness (Phase 2)Looking for participantsNCT06892548
What this trial is testing

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Who this might be right for
Advanced Lung Cancer
BioNTech SE 594
Large-scale testing (Phase 3)Not Yet RecruitingNCT06335355
What this trial is testing

A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Shanghai Shengdi Pharmaceutical Co., Ltd 401
Testing effectiveness (Phase 2)Study completedNCT00212043
What this trial is testing

Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma

Who this might be right for
Non Small Cell Lung Cancer
National University Hospital, Singapore 74
Load More Results